SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001572426-17-000013
Filing Date
2017-04-04
Accepted
2017-04-04 11:23:25
Documents
1
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 5481
  Complete submission text file 0001572426-17-000013.txt   7042
Mailing Address UNIT 5, SRAGH TECHNOLOGY PARK RAHAN ROAD TULLAMORE , CO. OFFALY L2 R35 FR98
Business Address UNIT 5, SRAGH TECHNOLOGY PARK RAHAN ROAD TULLAMORE , CO. OFFALY L2 R35 FR98 353 1 215 8100
Nexvet Biopharma plc (Issuer) CIK: 0001618561 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEXVET BIOPHARMA PLC NATL INST, FOSTERS AVENUE, MOUNT MERRION BLACKROCK L2 00000
Business Address
McCracken Joseph S (Reporting) CIK: 0001632454 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36828 | Film No.: 17736724